CICLOSPORIN EYEDROPS (Verkazia®)
Clinical Indication
Treatment of severe vernal keratoconjunctivitis (VKC) in children from 4 years of age and adolescents
Date of classification
April 2021
Yellow
Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .